| Lorus Therapeutics patents to protect lead anticancer target.(ribonucleotide reductase): An article from: BIOTECH Patent News | Digitalby Biotech Patent News (Publisher)
| List Price: | $5.95 | | | Available: | Available for download now |
| | Binding: | Digital | | Publisher: | Biotech Patent News | | Page Count: | 13 Pages | | Publication Date: | March 01, 2003 |
|
EDITORIAL REVIEWS |
Product Description
This digital document is an article from BIOTECH Patent News, published by Biotech Patent News on March 1, 2003. The length of the article is 3774 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation DetailsTitle: Lorus Therapeutics patents to protect lead anticancer target.(ribonucleotide reductase)Publication: BIOTECH Patent News (Newsletter)Date: March 1, 2003Publisher: Biotech Patent NewsVolume: 17 Issue: 3Distributed by Thomson Gale |
|
